Health Trials

About this trial

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.

Eligibility criteria

Qualifiers

ESKD patients who have sepsis condition with high interleukin-6 (IL-6 > 50 pg/ml)

Disqualifiers

Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.

Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.

Trial design

Treatments tested in this trial

  • Super High-flux dialyzer (Elisio 19HDx)
  • High-flux dialyzer (Elisio 19H)

Treatment groups

202 Participants
are divided into 2 treatment groups

Locations

1
Navamindhradhiraj university11130, DusitBangkok, Thailand

Sponsors and collaborators

Navamindradhiraj University

Lead sponsor

Source ClinicalTrials.gov